Effect of Dexamethasone in Hospitalized Patients with COVID-19 – Preliminary Report

Horby, Peter, Lim, Wei Shen, Emberson, Jonathan, Mafham, Marion, Bell, Jennifer, Linsell, Louise, Staplin, Natalie, Brightling, Christopher +19 more·2020·New England Journal of Medicine
DOI 10.1101/2020.06.22.20137273

Cited by (1,004)

Items 1,001–1,004 of 1,004

  1. Higher vs lower doses of dexamethasone in patients with COVID‐19 and severe hypoxia (COVID STEROID 2) trial: Protocol and statistical analysis plan
    Marie Warrer Munch, Anders Granholm, Sheila Nainan Myatra, BKT Vijayaraghavan, Maria Cronhjort, Rebecka Rubenson Wahlin, Stephan Matthias Jakob, Luca Cioccari, Maj‐Brit Nørregaard Kjær, Gitte Kingo Vesterlund et al. · 2021 · Acta Anaesthesiologica Scandinavica
  2. COVID-19 and Dentistry in 72 Questions: An Overview of the Literature
    Stéphane Derruau, Jérôme Bouchet, Ali Nassif, Alexandre Baudet, Kazutoyo Yasukawa, Sandrine Lorimier, Isabelle Prêcheur, Agnès Bloch‐Zupan, B. Pellat, Hélène Chardin et al. · 2021 · Journal of Clinical Medicine
  3. Covid-19 controversies: the tocilizumab chapter
    Erin K McCreary, Nuala J. Meyer · 2021 · BMJ
  4. Beyond dexamethasone, emerging immuno‐thrombotic therapies for COVID‐19
    Jensen, Melanie Peta, George, Marc, Gilroy, Derek, Sofat, Reecha · 2021 · British Journal of Clinical Pharmacology